Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: A role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway

Antioxidants and Redox Signaling

Volumn 14, Issue 3, 2011, Pages 469-487

  Cheng, Xinghua ^a   Siow, Richard C M ^a   Mann, Giovanni E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

KELCH LIKE ECH ASSOCIATED PROTEIN 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

AGING; ANGIOGENESIS; ANTIOXIDANT RESPONSIVE ELEMENT; CELL SURVIVAL; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION; INSULIN RESISTANCE; LONGEVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION;

AGING; ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, TYPE 2; ELECTRON TRANSPORT; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMANS; LONGEVITY; MICROFILAMENT PROTEINS; MITOCHONDRIA; NADPH OXIDASE; NF-E2-RELATED FACTOR 2; OBESITY; OXIDATION-REDUCTION; OXIDATIVE STRESS; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION;

EID: 78650913154     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3283     Document Type: Review

References (224)

1. Abdul-Ghani MA, Jani R, Chavez A, Molina-Carrion M, Tripathy D, and Defronzo RA. Mitochondrial reactive oxygen species generation in obese non-diabetic and type 2 diabetic participants. Diabetologia 52: 574-582, 2009.
2. Adams MR, Robinson J, McCredie R, Seale JP, Sorensen KE, Deanfield JE, and Celermajer DS. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 32: 123-127, 1998.
3. Alam J, Stewart D, Touchard C, Boinapally S, Choi AM, and Cook JL. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem 274: 26071-26078, 1999.
4. Aleksunes LM, Reisman SA, Yeager RL, Goedken MJ, and Klaassen CD. Nrf2 deletion impairs glucose tolerance and exacerbates hyperglycemia in Type 1 diabetic mice. J Pharmacol Exp Ther 333: 140-151, 2010.
5. Ali F, Zakkar M, Karu K, Lidington EA, Hamdulay SS, Boyle JJ, Zloh M, Bauer A, Haskard DO, Evans PC, and Mason JC. Induction of the cytoprotective enzyme heme oxygenase-1 by statins is enhanced in vascular endothe-lium exposed to laminar shear stress and impaired by disturbed flow. J Biol Chem 284: 18882-18892, 2009.
6. Ammar RF Jr., Gutterman DD, Brooks LA, and Dellsperger KC. Free radicals mediate endothelial dysfunction of coronary arterioles in diabetes. Cardiovasc Res 47: 595-601, 2000.
7. An JH and Blackwell TK. SKN-1 links C. elegans me-sendodermal specification to a conserved oxidative stress response. Genes Dev 17: 1882- 1893, 2003.
8. Antoniades C, Shirodaria C, Warrick N, Cai S, de Bono J, Lee J, Leeson P, Neubauer S, Ratnatunga C, Pillai R, Refsum H, and Channon KM. 5-Methyltetrahydrofolate rapidly improves endothelial function and decreases su-peroxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation 114: 1193-1201, 2006.
9. Anwar AA, Li FY, Leake DS, Ishii T, Mann GE, and Siow RC. Induction of heme oxygenase 1 by moderately oxidized low-density lipoproteins in human vascular smooth muscle cells: role of mitogen-activated protein kinases and Nrf2. Free Radic Biol Med 39: 227-236, 2005.
10. Apopa PL, He X, and Ma Q. Phosphorylation of Nrf2 in the transcription activation domain by casein kinase 2 (CK2) is critical for the nuclear translocation and transcription activation function of Nrf2 in IMR-32 neuroblastoma cells. J Biochem Mol Toxicol 22: 63-76, 2008.
11. Asija A, Peterson SJ, Stec DE, and Abraham NG. Targeting endothelial cells with heme oxygenase-1 gene using VE-cadherin promoter attenuates hyperglycemia-mediated cell injury and apoptosis. Antioxid Redox Signal 9: 2065-2074, 2007.
12. Avogaro A, Pagnin E, and Calo L. Monocyte NADPH ox-idase subunit p22(phox) and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients: relationship with oxidative stress. J Clin Endocrinol Metab 88: 1753-1759, 2003.
13. Babior BM. The NADPH oxidase of endothelial cells. IUBMB Life 50: 267-269, 2000.
14. Bannai S, Sato H, Ishii T, and Sugita Y. Induction of cystine transport activity in human fibroblasts by oxygen. J Biol Chem 264: 18480-18484, 1989.
15. Ba̧ star I, Seçkin S, Uysal M, and Aykaç-Toker G. Effect of streptozotocin on glutathione and lipid peroxide levels in various tissues of rats. Res Commun Mol Pathol Pharmacol, 102, 265-272, 1998
16. Beckman JA, Creager MA, and Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287: 2570-2581, 2002.
17. Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J, Hong M, Luther T, Henle T, Kloting I, Morcos M, Hofmann M, Tritschler H, Weigle B, Kasper M, Smith M, Perry G, Schmidt AM, Stern DM, Haring HU, Schleicher E, and Nawroth PP. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50: 2792-2808, 2001.
18. Bishop NA and Guarente L. Two neurons mediate diet-restriction-induced longevity in C. elegans. Nature 447: 545-549, 2007.
19. Bloom DA and Jaiswal AK. Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization=accumulation in the nucleus and tran-scriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J Biol Chem 278: 44675-44682, 2003.
20. Brodsky SV, Gealekman O, Chen J, Zhang F, Togashi N, Crabtree M, Gross SS, Nasjletti A, and Goligorsky MS. Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen. Circ Res 94: 377-384, 2004.
21. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46: 223-234, 1995.
22. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
23. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54: 1615-1625, 2005.
24. 2-induced apoptosis through functional codependence between HO-1 and AKT. Arterioscler Thromb Vasc Biol 26: 2027-2034, 2006.
25. Buckley BJ, Marshall ZM, and Whorton AR. Nitric oxide stimulates Nrf2 nuclear translocation in vascular endothe-lium. Biochem Biophys Res Commun 307: 973-979, 2003.
26. Cadenas E. Mitochondrial free radical production and cell signaling. Mol Aspects Med 25: 17-26, 2004.
27. Calkins MJ, Jakel RJ, Johnson DA, Chan K, Kan YW, and Johnson JA. Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proc Natl Acad Sci USA 102: 244-249, 2005.
28. Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, Kevil CG, and Lefer DJ. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 105: 365-374, 2009.
29. Cave AC, Brewer AC, Narayanapanicker A,RayR,Grieve DJ, Walker S, and Shah AM. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 8: 691-728, 2006.
30. Chan JY and Kwong M. Impaired expression of glutathione synthetic enzyme genes in mice with targeted deletion of the Nrf2 basic-leucine zipper protein. Biochim Biophys Acta 1517: 19-26, 2000.
31. Chan K, Han XD, and Kan YW. An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen. Proc Natl Acad Sci USA 98: 4611-4616, 2001.
32. Chan K, Lu R, Chang JC, and Kan YW. NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci USA 93: 13943-13948, 1996.
33. Chanas SA, Jiang Q, McMahon M, McWalter GK, McLellan LI, Elcombe CR, Henderson CJ, Wolf CR, Moffat GJ, Itoh K, Yamamoto M, and Hayes JD. Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and in-ducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem J 365: 405-416, 2002.
34. Chance B, Sies H, and Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 59: 527-605, 1979.
35. Chang SH, Garcia J, Melendez JA, Kilberg MS, and Agarwal A. Haem oxygenase 1 gene induction by glucose deprivation is mediated by reactive oxygen species via the mitochondrial electron-transport chain. Biochem J 371: 877-885, 2003.
36. Chen J, Patschan S, and Goligorsky MS. Stress-induced premature senescence of endothelial cells. J Nephrol 21: 337-344, 2008.
37. Chen XL, Dodd G, Thomas S, Zhang X, Wasserman MA, Rovin BH, and Kunsch C. Activation of Nrf2=ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am J Physiol Heart Circ Physiol 290: H1862-H1870, 2006.
38. Chen XL, Varner SE, Rao AS, Grey JY, Thomas S, Cook CK, Wasserman MA, Medford RM, Jaiswal AK, and Kunsch C. Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism. J Biol Chem 278: 703-711, 2003.
39. Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, Charng MJ, Wu TC, Chen LC, Ding YA, Pan WH, Jou YS, and Chau LY. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 111: 1-8, 2002.
40. Cho HY, Reddy SP, Debiase A, Yamamoto M, and Klee-berger SR. Gene expression profiling of NRF2-mediated protection against oxidative injury. Free Radic Biol Med 38: 325-343, 2005. (Pubitemid 40081112)
41. Churchman AT, Anwar AA, Li FY, Sato H, Ishii T, Mann GE, and Siow RC. Transforming growth factor-beta1 elicits Nrf2-mediated antioxidant responses in aortic smooth muscle cells. J Cell Mol Med 13: 2282-2292, 2009.
42. Cohen P and Frame S. The renaissance of GSK3. Nat Rev Mol Cell Biol 2: 769-776, 2001.
43. Collins AR, Lyon CJ, Xia X, Liu JZ, Tangirala RK, Yin F, Boy-adjian R, Bikineyeva A, Pratico D, Harrison DG, and Hsueh WA. Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes. Circ Res 104: e42-e54, 2009.
44. Converso DP, Taille C, Carreras MC, Jaitovich A, Poderoso JJ, and Boczkowski J. HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism. FASEB J 20: 1236-1238, 2006.
45. Coughlan MT, Thorburn DR, Penfold SA, Laskowski A, Harcourt BE, Sourris KC, Tan AL, Fukami K, Thallas-Bonke V, Nawroth PP, Brownlee M, Bierhaus A, Cooper ME, and Forbes JM. RAGE-induced cytosolic ROS promote mito-chondrial superoxide generation in diabetes. J Am Soc Ne-phrol 20: 742-752, 2009.
46. Crabtree MJ, Tatham AL, Hale AB, Alp NJ, and Channon KM. Critical role for tetrahydrobiopterin recycling by di-hydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: relative importance of the de novo biopterin synthesis versus salvage pathways. J Biol Chem 284: 28128-28136, 2009.
47. Dai G, Vaughn S, Zhang Y, Wang ET, Garcia-Cardena G, and Gimbrone MA Jr. Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase=Akt-dependent activation of Nrf2. Circ Res 101: 723-733, 2007.
48. Davidson SM and Duchen MR. Endothelial mitochondria: contributing to vascular function and disease. Circ Res 100: 1128-1141, 2007.
49. Devling TW, Lindsay CD, McLellan LI, McMahon M, and Hayes JD. Utility of siRNA against Keap1 as a strategy to stimulate a cancer chemopreventive phenotype. Proc Natl Acad Sci USA 102: 7280-7285A, 2005.
50. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yamamoto M, and Talalay P. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA 99: 11908-11913, 2002.
51. Dinkova-Kostova AT and Talalay P. Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol Nutr Food Res 52 Suppl 1: S128-S138, 2008.
52. Dixon LJ, Morgan DR, Hughes SM, McGrath LT, El-Sher-beeny NA, Plumb RD, Devine A, Leahey W, Johnston GD, and McVeigh GE. Functional consequences of endothelial nitric oxide synthase uncoupling in congestive cardiac failure. Circulation 107: 1725-1728, 2003.
53. Dreger H, Westphal K, Weller A, Baumann G, Stangl V, Meiners S, and Stangl K. Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection. Cardiovasc Res 83: 354-361, 2009.
54. Du X, Matsumura T, Edelstein D, Rossetti L, Zsengeller Z, Szabo C, and Brownlee M. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 112: 1049-1057, 2003.
55. Duan W, Zhang R, Guo Y, Jiang Y, Huang Y, Jiang H, and Li C. Nrf2 activity is lost in the spinal cord and its astrocytes of aged mice. In Vitro Cell Dev Biol Anim 45: 388-397, 2009.
56. Eggler AL, Liu G, Pezzuto JM, van Breemen RB, and Me-secar AD. Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proc Natl Acad Sci USA 102: 10070-10075, 2005.
57. Erusalimsky JD. Vascular endothelial senescence: from mechanisms to pathophysiology. J Appl Physiol 106: 326-332, 2009.
58. Fernandez-Checa JC, Garcia-Ruiz C, Colell A, Morales A, Mari M, Miranda M, and Ardite E. Oxidative stress: role of mitochondria and protection by glutathione. Biofactors 8: 7-11, 1998.
59. Finkel T and Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 408: 239-247, 2000.
60. Forstermann U. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med 5: 338-349, 2008.
61. Gao L and Mann GE. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc Res 82: 9-20, 2009.
62. Geraldes P, Yagi K, Ohshiro Y, He Z, Maeno Y, Yamamoto-Hiraoka J, Rask-Madsen C, Chung SW, Perrella MA, and King GL. Selective regulation of heme oxygenase-1 expression and function by insulin through IRS1= phosphoinositide 3-kinase=Akt-2 pathway. J Biol Chem 283: 34327-34336, 2008.
63. Ghosh S, Pulinilkunnil T, Yuen G, Kewalramani G, An D, Qi D, Abrahani A, and Rodrigues B. Cardiomyocyte apo-ptosis induced by short-term diabetes requires mitochon-drial GSH depletion. Am J Physiol Heart Circ Physiol 289: H768-H776, 2005.
64. Go YM, Park H, Koval M, Orr M, Reed M, Liang Y, Smith D, Pohl J, and Jones DP. A key role for mitochondria in endothelial signaling by plasma cysteine=cystine redox potential. Free Radic Biol Med 48: 275-283, 2010.
65. Godman CA, Chheda KP, Hightower LE, Perdrizet G, Shin DG, and Giardina C. Hyperbaric oxygen induces a cytoprotective and angiogenic response in human micro-vascular endothelial cells. Cell Stress Chaperones 15: 431- 442, 2010.
66. Goto H, Nishikawa T, Sonoda K, Kondo T, Kukidome D, Fujisawa K, Yamashiro T, Motoshima H, Matsumura T, Tsuruzoe K, and Araki E. Endothelial MnSOD over-expression prevents retinal VEGF expression in diabetic mice. Biochem Biophys Res Commun 366: 814-820, 2008.
67. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, and Channon KM. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105: 1656-1662, 2002.
68. Haigis MC and Sinclair DA. Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 5: 253-295, 2010.
69. Halliwell B. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemos-tasis 23 Suppl 1: 118-126, 1993.
70. Han Z, Varadharaj S, Giedt RJ, Zweier JL, Szeto HH, and Alevriadou BR. Mitochondria-derived reactive oxygen species mediate heme oxygenase-1 expression in sheared endothelial cells. J Pharmacol Exp Ther 329: 94-101, 2009.
71. Hansen JM, Watson WH, and Jones DP. Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. Toxicol Sci 82: 308-317, 2004.
72. Harrison EM, McNally SJ, Devey L, Garden OJ, Ross JA, and Wigmore SJ. Insulin induces heme oxygenase-1 through the phosphatidylinositol 3-kinase=Akt pathway and the Nrf2 transcription factor in renal cells. FEBS J 273: 2345-2356, 2006.
73. Hayashi T, Matsui-Hirai H, Miyazaki-Akita A, Fukatsu A, Funami J, Ding QF, Kamalanathan S, Hattori Y, Ignarro LJ, and Iguchi A. Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes. Proc Natl Acad Sci USA 103: 17018-17023, 2006.
74. Hayes JD, Chanas SA, Henderson CJ, McMahon M, Sun C, Moffat GJ, Wolf CR, and Yamamoto M. The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin. Biochem Soc Trans 28: 33-41, 2000.
75. He M, Siow RC, Sugden D, Gao L, Cheng X, and Mann GE. Induction of HO-1 and redox signaling in endothelial cells by advanced glycation end products: a role for Nrf2 in vascular protection in diabetes. Nutr Metab Cardiovasc Dis 2010.
76. Healy ZR, Lee NH, Gao X, Goldring MB, Talalay P, Kensler TW, and Konstantopoulos K. Divergent responses of chondrocytes and endothelial cells to shear stress: crosstalk among COX-2, the phase 2 response, and apoptosis. Proc Natl Acad Sci USA 102: 14010-14015, 2005.
77. Heiss EH, Schachner D, Werner ER, and Dirsch VM. Active NF-E2-related factor (Nrf2) contributes to keep endothelial NO synthase (eNOS) in the coupled state: the role of reactive oxygen species (ROS)-, eNOS- and heme oxygenase (HO-1) levels. J Biol Chem 284: 31579-31586, 2009.
78. Hosoya T, Maruyama A, Kang MI, Kawatani Y, Shibata T, Uchida K, Warabi E, Noguchi N, Itoh K, and Yamamoto M. Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. J Biol Chem 280: 27244-27250, 2005.
79. Hu CM, Lin HH, Chiang MT, Chang PF, and Chau LY. Systemic expression of heme oxygenase-1 ameliorates type 1 diabetes in NOD mice. Diabetes 56: 1240-1247, 2007.
80. Hu T, Ramachandrarao SP, Siva S, Valancius C, Zhu Y, Ma-hadev K, Toh I, Goldstein BJ, Woolkalis M, and Sharma K. Reactive oxygen species production via NADPH oxidase mediates TGF-beta-induced cytoskeletal alterations in endo-thelial cells. Am J Physiol Renal Physiol 289: F816-F825, 2005.
81. Huang HC, Nguyen T, and Pickett CB. Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. Proc Natl Acad Sci USA 97: 12475-12480, 2000.
82. Hurttila H, Koponen JK, Kansanen E, Jyrkkanen HK, Kivela A, Kylatie R, Yla-Herttuala S, and Levonen AL. Oxidative stress-inducible lentiviral vectors for gene therapy. Gene Ther 15: 1271-1279, 2008.
83. Imhoff BR and Hansen JM. Extracellular redox status regulates Nrf2 activation through mitochondrial reactive oxygen species. Biochem J 424: 491-500, 2009.
84. Imrie H, Abbas A, and Kearney M. Insulin resistance, li-potoxicity and endothelial dysfunction. Biochim Biophys Acta 1801: 320-326, 2010.
85. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Ut-sumi H, and Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxi-dase in cultured vascular cells. Diabetes 49: 1939-1945, 2000.
86. Ishii T, Itoh K, Ruiz E, Leake DS, Unoki H, Yamamoto M, and Mann GE. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ Res 94: 609-616, 2004.
87. Ishii T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S, and Yamamoto M. Transcription factor Nrf2 co-ordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 275: 16023-16029, 2000.
88. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, and Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13: 76-86, 1999.
89. Jain AK and Jaiswal AK. GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J Biol Chem 282: 16502-16510, 2007.
90. Jain AK and Jaiswal AK. Phosphorylation of tyrosine 568 controls nuclear export of Nrf2. J Biol Chem 281: 12132-12142, 2006.
91. Jain AK, Mahajan S, and Jaiswal AK. Phosphorylation and dephosphorylation of tyrosine 141 regulate stability and degradation of INrf2: a novel mechanism in Nrf2 activation. J Biol Chem 283: 17712-17720, 2008.
92. Jain SK, Bull R, Rains JL, Bass PF, Levine SN, Reddy S, McVie R, and Bocchini JA. Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation? Antioxid Redox Signal 12: 1333-1337, 2010.
93. Ji LL, Gomez-Cabrera MC, and Vina J. Exercise and hormesis: activation of cellular antioxidant signaling pathway. Ann N Y Acad Sci 1067: 425-435, 2006.
94. Jiang T, Huang Z, Lin Y, Zhang Z, Fang D, and Zhang DD. The protective role of Nrf2 in STZ-induced diabetic ne-phropathy. Diabetes 59: 850-860, 2010.
95. Jones DP, Mody VC Jr., Carlson JL, Lynn MJ, and Sternberg P Jr. Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic Biol Med 33: 1290-1300, 2002.
96. Kang ES, Woo IS, Kim HJ, Eun SY, Paek KS, Kim HJ, Chang KC, Lee JH, Lee HT, Kim JH, Nishinaka T, Yabe-Nishimura C, and Seo HG. Up-regulation of aldose reductase expression mediated by phosphatidylinositol 3-kinase=Akt and Nrf2 is involved in the protective effect of curcumin against oxidative damage. Free Radic Biol Med 43: 535-545, 2007.
97. Kang MI, Kobayashi A, Wakabayashi N, Kim SG, and Yamamoto M. Scaffolding of Keap1 to the actin cytoskele-ton controls the function of Nrf2 as key regulator of cyto-protective phase 2 genes. Proc Natl Acad Sci USA 101: 2046-2051, 2004.
98. Kapeta S, Chondrogianni N, and Gonos ES. Nuclear erythroid factor 2 (Nrf2) mediated proteasome activation delays senescence in human fibroblasts. J Biol Chem 285: 8171-8184, 2010.
99. Kass DA, Shapiro EP, Kawaguchi M, Capriotti AR, Scuteri A, deGroof RC, and Lakatta EG. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 104: 1464-1470, 2001.
100. Katoh Y, Iida K, Kang MI, Kobayashi A, Mizukami M, Tong KI, McMahon M, Hayes JD, Itoh K, and Yamamoto M. Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome. Arch Biochem Biophys 433: 342-350, 2005.
101. Kim JA, Montagnani M, Koh KK, and Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113: 1888-1904, 2006.
102. Kim JY, Cho HJ, Sir JJ,KimBK,HurJ,Youn SW, Yang HM, Jun SI, Park KW, Hwang SJ, Kwon YW, Lee HY, Kang HJ,OhBH, Park YB, and Kim HS. Sulfasalazine induces haem oxygenase-1 via ROS-dependent Nrf2 signalling, leading to control of neointimal hyperplasia. Cardiovasc Res 82: 550-560, 2009.
103. Kim YC, Yamaguchi Y, Kondo N, Masutani H, and Yodoi J. Thioredoxin-dependent redox regulation of the antioxidant responsive element (ARE) in electrophile response. Onco-gene 22: 1860-1865, 2003.
104. Kim YK, Lee MS, Son SM, Kim IJ, Lee WS, Rhim BY, Hong KW, and Kim CD. Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes. Diabetes 51: 522-527, 2002.
105. Kiritoshi S, Nishikawa T, Sonoda K, Kukidome D, Seno-kuchi T, Matsuo T, Matsumura T, Tokunaga H, Brownlee M, and Araki E. Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes 52: 2570-2577, 2003.
106. Kobayashi M, Li L, Iwamoto N, Nakajima-Takagi Y, Kaneko H, Nakayama Y, Eguchi M, Wada Y, Kumagai Y, and Yamamoto M. The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Mol Cell Biol 29: 493-502, 2009.
107. Kruger AL, Peterson S, Turkseven S, Kaminski PM, Zhang FF, Quan S, Wolin MS, and Abraham NG. D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes. Circulation 111: 3126-3134, 2005.
108. Kwak MK, Kensler TW, and Casero RA Jr. Induction of phase 2 enzymes by serum oxidized polyamines through activation of Nrf2: effect of the polyamine metabolite acrolein. Biochem Biophys Res Commun 305: 662-670, 2003.
109. Kweon MH, In Park Y, Sung HC, and Mukhtar H. The novel antioxidant 3-O-caffeoyl-1-methylquinic acid induces Nrf2- dependent phase II detoxifying genes and alters intracellular glutathione redox. Free Radic Biol Med 40: 1349-1361, 2006
110. Lacraz G, Figeac F, Movassat J, Kassis N, Coulaud J, Galinier A, Leloup C, Bailbe D, Homo-Delarche F, and Portha B. Diabetic beta-cells can achieve self-protection against oxidative stress through an adaptive up-regulation of their antioxidant defenses. PLoS ONE 4: e6500, 2009.
111. Langston W, Circu ML, and Aw TY. Insulin stimulation of gamma-glutamylcysteine ligase catalytic subunit expression increases endothelial GSH during oxidative stress: influence of low glucose. Free Radic Biol Med 45: 1591-1599, 2008.
112. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, and Harrison DG. En-dothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103: 1282-1288, 2001.
113. Lee MY and Griendling KK. Redox signaling, vascular function, and hypertension. Antioxid Redox Signal 10: 1045-1059, 2008.
114. Leiser SF and Miller RA. Nrf2 signaling, a mechanism for cellular stress resistance in long-lived mice. Mol Cell Biol 30: 871-884, 2010.
115. Leonarduzzi G, Robbesyn F, and Poli G. Signaling kinases modulated by 4-hydroxynonenal. Free Radic Biol Med 37: 1694-1702, 2004.
116. Levonen AL, Inkala M, Heikura T, Jauhiainen S, Jyrkkanen HK, Kansanen E, Maatta K, Romppanen E, Turunen P, Ru-tanen J, and Yla-Herttuala S. Nrf2 gene transfer induces an-tioxidant enzymes and suppresses smooth muscle cell growth in vitro and reduces oxidative stress in rabbit aorta in vivo. Arterioscler Thromb Vasc Biol 27: 741-747, 2007.
117. Li M, Liu RM, Timblin CR, Meyer SG, Mossman BT, and Fukagawa NK. Age affects ERK1=2 and NRF2 signaling in the regulation of GCLC expression. J Cell Physiol 206: 518-525, 2006.
118. Limon-Pacheco JH, Hernandez NA, Fanjul-Moles ML, and Gonsebatt ME. Glutathione depletion activates mitogen-activated protein kinase (MAPK) pathways that display organ-specific responses and brain protection in mice. Free Radic Biol Med 43: 1335-1347, 2007.
119. Liu XM, Peyton KJ, Ensenat D, Wang H, Hannink M, Alam J, and Durante W. Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2=ARE complex to promote vascular smooth muscle cell survival. Cardiovasc Res 75: 381-389, 2007.
120. Liu XM, Peyton KJ, Ensenat D, Wang H, Schafer AI, Alam J, and Durante W. Endoplasmic reticulum stress stimulates heme oxygenase-1 gene expression in vascular smooth muscle. Role in cell survival. J Biol Chem 280: 872-877, 2005.
121. 2 generation play a key role in flow-mediated dilation in human coronary resistance arteries. Circ Res 93: 573-580, 2003.
122. Lo SC and Hannink M. PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria. Exp Cell Res 314: 1789-1803, 2008.
123. Loboda A, Jazwa A, Grochot-Przeczek A, Rutkowski AJ, Cisowski J, Agarwal A, Jozkowicz A, and Dulak J. Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 10: 1767-1812, 2008.
124. Lu SC. Regulation of glutathione synthesis. Mol Aspects Med 30: 42-59, 2009.
125. Luan R, Liu S, Yin T, Lau WB, Wang Q, Guo W, Wang H, and Tao L. High glucose sensitizes adult cardiomyocytes to ischaemia=reperfusion injury through nitrative thioredoxin inactivation. Cardiovasc Res 83: 294-302, 2009.
126. Maechler P and Wollheim CB. Mitochondrial function in normal and diabetic beta-cells. Nature 414: 807-812, 2001.
127. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37: 517-554, 1997.
128. Mann GE, Bonacasa B, Ishii T, and Siow RC. Targeting the redox sensitive Nrf2-Keap1 defense pathway in cardiovascular disease: protection afforded by dietary iso-flavones. Curr Opin Pharmacol 9: 139-145, 2009.
129. Mann GE, Rowlands DJ, Li FY, de Winter P, and Siow RC. Activation of endothelial nitric oxide synthase by dietary isoflavones: role of NO in Nrf2-mediated antioxidant gene expression. Cardiovasc Res 75: 261-274, 2007.
130. Mann GE, Yudilevich DL, and Sobrevia L. Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 83: 183-252, 2003.
131. McClung JP, Roneker CA, Mu W, Lisk DJ, Langlais P, Liu F, and Lei XG. Development of insulin resistance and obesity in mice overexpressing cellular glutathione perox-idase. Proc Natl Acad Sci USA 101: 8852-8857, 2004.
132. McMahon M, Itoh K, Yamamoto M, and Hayes JD. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem 278: 21592-21600, 2003.
133. Minamino T and Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ Res 100: 15-26, 2007.
134. Miyata T, Sugiyama S, Suzuki D, Inagi R, and Kurokawa K. Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy. Kidney Int Suppl 71: S54-S56, 1999.
135. Moncada S, Palmer RM, and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
136. Motohashi H and Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 10: 549-557, 2004.
137. Murphy MP. Induction of mitochondrial ROS production by electrophilic lipids: a new pathway of redox signaling? Am J Physiol Heart Circ Physiol 290: H1754-H1755, 2006.
138. Naidu S, Vijayan V, Santoso S, Kietzmann T, and Im-menschuh S. Inhibition and genetic deficiency of p38 MAPK up-regulates heme oxygenase-1 gene expression via Nrf2. J Immunol 182: 7048-7057, 2009.
139. Ndisang JF, Lane N, Syed N, and Jadhav A. Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats. Endocrinology 151: 549-560, 2010.
140. Nishikawa T, Edelstein D, and Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl 77: S26-S30, 2000.
141. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hy-perglycaemic damage. Nature 404: 787-790, 2000.
142. Nishinaka T and Yabe-Nishimura C. Transcription factor Nrf2 regulates promoter activity of mouse aldose reductase (AKR1B3) gene. J Pharmacol Sci 97: 43-51, 2005.
143. Niture SK, Jain AK, and Jaiswal AK. Antioxidant-induced modification of INrf2 cysteine 151 and PKC-delta-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance. J Cell Sci 122: 4452-4464, 2009.
144. Okouchi M, Okayama N, Alexander JS, and Aw TY. NRF2-dependent glutamate-L-cysteine ligase catalytic subunit expression mediates insulin protection against hyperglyce-mia-induced brain endothelial cell apoptosis. Curr Neuro-vasc Res 3: 249-261, 2006.
145. Okouchi M, Okayama N, and Aw TY. Preservation of cellular glutathione status and mitochondrial membrane potential by N-acetylcysteine and insulin sensitizers prevent carbonyl stress-induced human brain endothelial cell apo-ptosis. Curr Neurovasc Res 6: 267-278, 2009.
146. Onken B and Driscoll M. Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. PLoS ONE 5: e8758, 2010.
147. Orasanu G and Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 53: S35-S42, 2009.
148. Osburn WO, Wakabayashi N, Misra V, Nilles T, Biswal S, Trush MA, and Kensler TW. Nrf2 regulates an adaptive response protecting against oxidative damage following diquat-mediated formation of superoxide anion. Arch Bio-chem Biophys 454: 7-15, 2006.
149. Pacher P, Beckman JS, and Liaudet L. Nitric oxide and per-oxynitrite in health and disease. Physiol Rev 87: 315-424, 2007.
150. Pae HO, Jeong GS, Jeong SO, Kim HS, Kim SA, Kim YC, Yoo SJ, Kim HD, and
151. Papaiahgari S, Zhang Q, Kleeberger SR, Cho HY, and Reddy SP. Hyperoxia stimulates an Nrf2-ARE transcrip-tional response via ROS-EGFR-PI3K-Akt=ERK MAP kinase signaling in pulmonary epithelial cells. Antioxid Redox Signal 8: 43-52, 2006.
152. Pearson KJ, Lewis KN, Price NL, Chang JW, Perez E, Cascajo MV, Tamashiro KL, Poosala S, Csiszar A, Ungvari Z, Kensler TW, Yamamoto M, Egan JM, Longo DL, Ingram DK, Navas P, and de Cabo R. Nrf2 mediates cancer protection but not prolongevity induced by caloric restriction. Proc Natl Acad Sci USA 105: 2325-2330, 2008.
153. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, and Shulman GI. Mi-tochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300: 1140-1142, 2003.
154. Piconi L, Quagliaro L, Assaloni R, Da RR, Maier A, Zuodar G, and Ceriello A. Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diabetes Metab Res Rev 22: 198-203, 2006.
155. Purdom-Dickinson SE, Sheveleva EV, Sun H, and Chen QM. Translational control of nrf2 protein in activation of antioxi-dant response by oxidants. Mol Pharmacol 72: 1074-1081, 2007.
156. Quintero M, Colombo SL, Godfrey A, and Moncada S. Mitochondria as signaling organelles in the vascular en-dothelium. Proc Natl Acad Sci USA 103: 5379-5384, 2006.
157. Rask-Madsen C and King GL. Mechanisms of disease: en-dothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab 3: 46-56, 2007.
158. Ribeiro MM, Klein D, Pileggi A, Molano RD, Fraker C, Ricordi C, Inverardi L, and Pastori RL. Heme oxygenase-1 fused to a TAT peptide transduces and protects pancreatic beta-cells. Biochem Biophys Res Commun 305: 876-881, 2003.
159. Ricart KC, Bolisetty S, Johnson MS, Perez J, Agarwal A, Murphy MP, and Landar A. The permissive role of mito- chondria in the induction of haem oxygenase-1 in endo-thelial cells. Biochem J 419: 427-436, 2009.
160. Rizzardini M, Lupi M, Bernasconi S, Mangolini A, and Cantoni L. Mitochondrial dysfunction and death in motor neurons exposed to the glutathione-depleting agent etha-crynic acid. J Neurol Sci 207: 51-58, 2003.
161. Ross D, Kepa JK, Winski SL, Beall HD, Anwar A, and Siegel D. NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem Biol Interact 129: 77-97, 2000.
162. Sakurai A, Nishimoto M, Himeno S, Imura N, Tsujimoto M, Kunimoto M, and Hara S. Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: role of NF-E2-related factor-2. J Cell Phy-siol 203: 529-537, 2005.
163. Salazar M, Rojo AI, Velasco D, de Sagarra RM, and Cua-drado A. Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phos-phorylation and nuclear exclusion of the transcription factor Nrf2. J Biol Chem 281: 14841-14851, 2006.
164. Santos DL, Palmeira CM, Seica R, Dias J, Mesquita J, Moreno AJ, and Santos MS. Diabetes and mitochondrial oxidative stress: a study using heart mitochondria from the diabetic Goto-Kakizaki rat. Mol Cell Biochem 246: 163-170, 2003.
165. Sasaki H, Sato H, Kuriyama-Matsumura K, Sato K, Mae-bara K, Wang H, Tamba M, Itoh K, Yamamoto M, and Bannai S. Electrophile response element-mediated induction of the cystine=glutamate exchange transporter gene expression. J Biol Chem 277: 44765-44771, 2002.
166. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, and Stern D. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96: 1395-1403, 1995.
167. Schulz E, Jansen T, Wenzel P, Daiber A, and Munzel T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and en-dothelial dysfunction in hypertension. Antioxid Redox Signal 10: 1115-1126, 2008.
168. Sengoelge G, Fodinger M, Skoupy S, Ferrara I, Zangerle C, Rogy M, Horl WH, Sunder-Plassmann G, and Menzel J. Endothelial cell adhesion molecule and PMNL response to inflammatory stimuli and AGE-modified fibronectin. Kidney Int 54: 1637-1651, 1998.
169. Shih AY, Imbeault S, Barakauskas V, Erb H, Jiang L, Li P, and Murphy TH. Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J Biol Chem 280: 22925-22936, 2005.
170. Shih PH and Yen GC. Differential expressions of antioxi-dant status in aging rats: the role of transcriptional factor Nrf2 and MAPK signaling pathway. Biogerontology 8: 71-80, 2007.
171. Shin S, Wakabayashi J, Yates MS, Wakabayashi N, Dolan PM, Aja S, Liby KT, Sporn MB, Yamamoto M, and Kensler TW. Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide. Eur J Pharmacol 620: 138-144, 2009.
172. Singh SP, Niemczyk M, Saini D, Sadovov V, Zimniak L, and Zimniak P. Disruption of the mGsta4 gene increases life span of C57BL mice. J Gerontol A Biol Sci Med Sci 65: 14- 23, 2010.
173. Siow RC, Li FY, Rowlands DJ, de Winter P, and Mann GE. Cardiovascular targets for estrogens and phytoestrogens: transcriptional regulation of nitric oxide synthase and anti-oxidant defense genes. Free Radic Biol Med 42: 909-925, 2007
174. Siow RC, Sato H, and Mann GE. Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide? Cardiovasc Res 41: 385-394, 1999.
175. Solowiej E, Solowiej J, Godlewski M, Motyl T, Perkowska-Ptasinska A, Jaskiewicz K, Kasprzycka-Guttman T, and Rowinski W. Application of sulforaphane: histopathologi-cal study of intraportal transplanted pancreatic islets into livers of diabetic rats. Transplant Proc 38: 282-283, 2006.
176. Song J, Sumiyoshi S, Nakashima Y, Doi Y, Iida M, Kiyohara Y, and Sueishi K. Overexpression of heme oxygenase-1 in coronary atherosclerosis of Japanese autopsies with diabetes mellitus: Hisayama study. Atherosclerosis 202: 573-581, 2009.
177. Sparks LM, Xie H, Koza RA, Mynatt R, Hulver MW, Bray GA, and Smith SR. A high-fat diet coordinately down-regulates genes required for mitochondrial oxidative phos-phorylation in skeletal muscle. Diabetes 54: 1926-1933, 2005.
178. Stadler K, Jenei V, von BG, Somogyi A, and Jakus J. Increased nitric oxide levels as an early sign of premature aging in diabetes. Free Radic Biol Med 35: 1240-1251, 2003.
179. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, and Baron AD. Obesity=insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97: 2601-2610, 1996.
180. Storozhevykh TP, Senilova YE, Persiyantseva NA, Pinelis VG, and Pomytkin IA. Mitochondrial respiratory chain is involved in insulin-stimulated hydrogen peroxide production and plays an integral role in insulin receptor autophosphorylation in neurons. BMC Neurosci 8: 84, 2007.
181. Sugimoto R, Warabi E, Katayanagi S, Sakai S, Uwayama J, Yanagawa T, Watanabe A, Harada H, Kitamura K, No-guchi N, Yoshida H, Siow RC, Mann GE, and Ishii T. Enhanced neointimal hyperplasia and carotid artery remodeling in sequestosome 1 deficient mice. J Cell Mol Med 2009 Sep 24 [Epub ahead of print].
182. Suh JH, Shenvi SV, Dixon BM, Liu H, Jaiswal AK, Liu RM, and Hagen TM. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci USA 101: 3381-3386, 2004.
183. Suliman HB, Carraway MS, Tatro LG, and Piantadosi CA. A new activating role for CO in cardiac mitochondrial biogenesis. J Cell Sci 120: 299-308, 2007.
184. Sun J, Brand M, Zenke Y, Tashiro S, Groudine M, and Ig-arashi K. Heme regulates the dynamic exchange of Bach1 and NF-E2-related factors in the Maf transcription factor network. Proc Natl Acad Sci USA 101: 1461-1466, 2004.
185. Sussan TE, Jun J, Thimmulappa R, Bedja D, Antero M, Gab-rielson KL, Polotsky VY, and Biswal S. Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-medi-ated atherosclerosis in mice. PLoS ONE 3: e3791, 2008.
186. Sykiotis GP and Bohmann D. Keap1=Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila. Dev Cell 14: 76-85, 2008.
187. Szabo C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6: 917-935, 2007.
188. Tanaka Y, Aleksunes LM, Yeager RL, Gyamfi MA, Esterly N, Guo GL, and Klaassen CD. NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet. J Pharmacol Exp Ther 325: 655-664, 2008.
189. Tanito M, Agbaga MP, and Anderson RE. Upregulation of thioredoxin system via Nrf2-antioxidant responsive element pathway in adaptive-retinal neuroprotection in vivo and in vitro. Free Radic Biol Med 42: 1838-1850, 2007.
190. Terry DF, Wilcox MA, McCormick MA, and Perls TT. Cardiovascular disease delay in centenarian offspring. J Gerontol A Biol Sci Med Sci 59: 385-389, 2004.
191. Thomas SR, Witting PK, and Drummond GR. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal 10: 1713-1765, 2008.
192. Tullet JM, Hertweck M, An JH, Baker J, Hwang JY, Liu S, Oliveira RP, Baumeister R, and Blackwell TK. Direct inhibition of the longevity-promoting factor SKN-1 by insulinlike signaling in C. elegans. Cell 132: 1025-1038, 2008.
193. Unterluggauer H, Hampel B, Zwerschke W, and Jansen-Durr P. Senescence-associated cell death of human endo-thelial cells: the role of oxidative stress. Exp Gerontol 38: 1149-1160, 2003.
194. Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y, Fuji-moto M, Quinn MT, Pagano PJ, Johnson C, and Alexander RW. Novel role of gp91(phox)-containing NAD(P)H oxi-dase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 91: 1160-1167, 2002.
195. Vallance P, Collier J, and Moncada S. Effects of endotheli-um-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2: 997-1000, 1989.
196. Van Buul JD, Fernandez-Borja M, Anthony EC, and Hor-dijk PL. Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid Redox Signal 7: 308-317, 2005.
197. Vavuranakis M, Stefanadis C, Triandaphyllidi E, Toutouzas K, and Toutouzas P. Coronary artery distensibility in diabetic patients with simultaneous measurements of luminal area and intracoronary pressure: evidence of impaired reactivity to nitroglycerin. J Am Coll Cardiol 34: 1075-1081, 1999.
198. Venugopal R and Jaiswal AK. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:qui-none oxidoreductase1 gene. Proc Natl Acad Sci USA 93: 14960-14965, 1996.
199. Wakabayashi N, Itoh K, Wakabayashi J, Motohashi H, Noda S, Takahashi S, Imakado S, Kotsuji T, Otsuka F, Roop DR, Harada T, Engel JD, and Yamamoto M. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet 35: 238-245, 2003.
200. Wang L, Chen Y, Sternberg P, and Cai J. Essential roles of the PI3 kinase=Akt pathway in regulating Nrf2-dependent antioxidant functions in the RPE. Invest Ophthalmol Vis Sci 49: 1671-1678, 2008.
201. Wang W, Fang H, Groom L, Cheng A, Zhang W, Liu J, Wang X, Li K, Han P, Zheng M, Yin J, Wang W, Mattson MP, Kao JP, Lakatta EG, Sheu SS, Ouyang K, Chen J, Dirksen RT, and Cheng H. Superoxide flashes in single mitochondria. Cell 134: 279-290, 2008.
202. Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, and Wautier JL. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 280: E685-E694, 2001.
203. Winiarska K, Drozak J, Wegrzynowicz M, Fraczyk T, and Bryla J. Diabetes-induced changes in glucose synthesis, intracellular glutathione status and hydroxyl free radical generation in rabbit kidney-cortex tubules. Mol Cell Biochem 261: 91-98, 2004.
204. Wolin MS, Ahmad M, and Gupte SA. Oxidant and redox signaling in vascular oxygen sensing mechanisms: basic concepts, current controversies, and potential importance of cytosolic NADPH. Am J Physiol Lung Cell Mol Physiol 289: L159-L173, 2005.
205. Xue M, Qian Q, Adaikalakoteswari A, Rabbani N, Babaei-Jadidi R, and Thornalley PJ. Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease. Diabetes 57: 2809-2817, 2008.
206. Yamamoto M, Yamato E, Toyoda S, Tashiro F, Ikegami H, Yodoi J, and Miyazaki J. Transgenic expression of antioxi-dant protein thioredoxin in pancreatic beta cells prevents progression of type 2 diabetes mellitus. Antioxid Redox Signal 10: 43-49, 2008.
207. Yamawaki H, Pan S, Lee RT, and Berk BC. Fluid shear stress inhibits vascular inflammation by decreasing thior-edoxin-interacting protein in endothelial cells. J Clin Invest 115: 733-738, 2005.
208. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, and Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors=binding proteins. J Biol Chem 269: 9889-9897, 1994.
209. Yan SF, D'Agati V, Schmidt AM, and Ramasamy R. Receptor for advanced glycation endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging. Curr Mol Med 7: 699-710, 2007.
210. Yan SF, Ramasamy R, and Schmidt AM. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. Nat Clin Pract Endocrinol Metab 4: 285-293, 2008.
211. Ye G, Metreveli NS, Donthi RV, Xia S, Xu M, Carlson EC, and Epstein PN. Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 53: 1336-1343, 2004.
212. Yoh K, Hirayama A, Ishizaki K, Yamada A, Takeuchi M, Yamagishi S, Morito N, Nakano T, Ojima M, Shimohata H, Itoh K, Takahashi S, and Yamamoto M. Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice. Genes Cells 13: 1159-1170, 2008.
213. Yu T, Robotham JL, and Yoon Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci USA 103: 2653-2658, 2006.
214. Yusuf M, Kwong Huat BT, Hsu A, Whiteman M, Bhatia M, and Moore PK. Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis. Biochem Biophys Res Commun 333: 1146-1152, 2005.
215. Zakkar M, Van Der HK, Luong LA, Chaudhury H, Cuhl-mann S, Hamdulay SS, Krams R, Edirisinghe I, Rahman I, Carlsen H, Haskard DO, Mason JC, and Evans PC. Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state. Arterioscler Thromb Vasc Biol 29: 1851-1857, 2009.
216. Zaman MB, Leonard MO, Ryan EJ, Nolan NP, Hoti E, Maguire D, Mulcahy H, Traynor O, Taylor CT, Hegarty JE, Geoghegan JG, and O'Farrelly C. Lower expression of Nrf2 mRNA in older donor livers: a possible contributor to increased ischemia-reperfusion injury? Transplantation 84: 1272-1278, 2007.
217. Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, Grujic D, Hagen T, Vidal-Puig AJ, Boss O, Kim YB, Zheng XX, Wheeler MB, Shulman GI, Chan CB, and Lowell BB. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 105: 745-755, 2001.
218. Zhang HS and Wang SQ. Nrf2 is involved in the effect of tanshinone IIA on intracellular redox status in human aortic smooth muscle cells. Biochem Pharmacol 73: 1358-1366, 2007.
219. Zhang X, Chen X, Song H, Chen HZ, and Rovin BH. Activation of the Nrf2=antioxidant response pathway increases IL-8 expression. Eur J Immunol 35: 3258-3267, 2005.
220. Zhao J, Kobori N, Aronowski J, and Dash PK. Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci Lett 393: 108-112, 2006.
221. Zhao J, Moore AN, Redell JB, and Dash PK. Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury. J Neurosci 27: 10240-10248, 2007.
222. Zhong L, Liu Z, Yan R, Johnson S, Zhao Y, Fang X, and Cao D. Aldo-keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levels. Biochem Biophys Res Commun 387: 245-250, 2009.
223. Zhu H, Itoh K, Yamamoto M, Zweier JL, and Li Y. Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: protection against reactive oxygen and nitrogen species-induced cell injury. FEBS Lett 579: 3029-3036, 2005.
224. Zimmet P, Alberti KG, and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414: 782-787, 2001.